Evidence map›Paper›PMID 33494337›Full record

ArticleNanomaterials (Basel, Switzerland)2021

A Perfusion Bioreactor for Longitudinal Monitoring of Bioengineered Liver Constructs.

Lisa Sassi, Omolola Ajayi, Sara Campinoti, Dipa Natarajan, Claire McQuitty, Riccardo Rayan Siena, Sara Mantero, Paolo De Coppi, Alessandro F Pellegata, Shilpa Chokshi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Lessons Learned from Liver-on-Chip Platform.Annals of biomedical engineering · 2025
    Review
  4. Review
  5. Moving Toward Biomimetic Tissue-Engineered Scaffolds.Nanomaterials (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Engineering complexity in human tissue models of cancer.Advanced drug delivery reviews · 2022
    Review
  10. Recent Advances in Liver Engineering With Decellularized Scaffold.Frontiers in bioengineering and biotechnology · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Lisa SassiInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.
Omolola AjayiInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.
Sara CampinotiInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.ORCID 0000-0003-0056-5792
Dipa NatarajanInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.
Claire McQuittyInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.
Riccardo Rayan SienaInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.
Sara ManteroDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milan, 20133 Milan, Italy.ORCID 0000-0002-1264-0465
Paolo De CoppiStem Cells and Regenerative Medicine and Biomedical Research Center, NIHR, Great Ormond Street, Institute of Child Health, UCL, London WC1N 1EH, UK.
Alessandro F PellegataDepartment of Chemistry, Materials and Chemical Engineering "Giulio Natta", Politecnico di Milan, 20133 Milan, Italy.
Shilpa ChokshiInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.
Luca UrbaniInstitute of Hepatology, Foundation for Liver Research, London SE5 9NT, UK.ORCID 0000-0002-4988-552X
King's College London · GBGreat Ormond Street Hospital · GBPolitecnico di Milano · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the field of in vitro liver disease models, decellularised organ scaffolds maintain the original biomechanical and biological properties of the extracellular matrix and are established supports for in vitro cell culture. However, tissue engineering approaches based on whole organ decellularized scaffolds are hampered by the scarcity of appropriate bioreactors that provide controlled 3D culture conditions. Novel specific bioreactors are needed to support long-term culture of bioengineered constructs allowing non-invasive longitudinal monitoring. Here, we designed and validated a specific bioreactor for long-term 3D culture of whole liver constructs. Whole liver scaffolds were generated by perfusion decellularisation of rat livers. Scaffolds were seeded with Luc+HepG2 and primary human hepatocytes and cultured in static or dynamic conditions using the custom-made bioreactor. The bioreactor included a syringe pump, for continuous unidirectional flow, and a circuit built to allow non-invasive monitoring of culture parameters and media sampling. The bioreactor allowed non-invasive analysis of cell viability, distribution, and function of Luc+HepG2-bioengineered livers cultured for up to 11 days. Constructs cultured in dynamic conditions in the bioreactor showed significantly higher cell viability, measured with bioluminescence, distribution, and functionality (determined by albumin production and expression of CYP enzymes) in comparison to static culture conditions. Finally, our bioreactor supports primary human hepatocyte viability and function for up to 30 days, when seeded in the whole liver scaffolds. Overall, our novel bioreactor is capable of supporting cell survival and metabolism and is suitable for liver tissue engineering for the development of 3D liver disease models.

Indexed as

bioluminescencebioreactordecellularizationextracellular matrixlivertissue engineering

Identifiers

PMID33494337
PMCPMC7912543
OpenAlexW3123790461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.